References
- Almeida, L., B. Azevedo, T. Nunes, M. Vaz-da-Silva, and P. Soares-da-Silva. 2007. Why healthy subjects volunteer for phase I studies and how they perceive their participation? European Journal of Clinical Pharmacology 63 (11):1085–94. doi: https://doi.org/10.1007/s00228-007-0368-3.
- Appelbaum, P., L. H. Roth, C. W. Lidz, P. Benson, and W. Winslade. 1987. False hopes and best data: consent to research and the therapeutic misconception. The Hastings Center Report 17 (2):20–4. doi: https://doi.org/10.2307/3562038.
- BRAIN Initiative. 2014. Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Working Group. “Brain 2025: A Scientific Vision.” National Institutes of Health. https://braininitiative.nih.gov/sites/default/files/pdfs/brain2025_508c.pdf.
- BRAIN Initiative. 2019. Advisory Committee to the NIH Director BRAIN Initiative Working Group 2.0. “The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative 2.0: From Cells to Circuits, Toward Cures.” National Institutes of Health. https://braininitiative.nih.gov/sites/default/files/images/brain_2.0_6-6-19-final_revised10302019_508c.pdf.
- Chiong, W., M. K. Leonard, and E. F. Chang. 2018. Neurosurgical patients as human research subjects: Ethical considerations in intracranial electrophysiology research. Neurosurgery 83 (1):29–37. doi: https://doi.org/10.1093/neuros/nyx361.
- Clapp, J. T., A. F. Arriaga, S. Murthy, S. E. Raper, J. Sanford Schwartz, F. K. Barg, and L. A. Fleisher. 2019. Surgical consultation as social process: Implications for shared decision making. Annals of Surgery 269 (3):446–52. doi: https://doi.org/10.1097/sla.0000000000002610.
- Cooper, J. A., H. J. Sagar, S. M. Doherty, N. Jordan, P. Tidswell, and E. V. Sullivan. 1992. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson’s disease: A follow-up study of untreated patients. Brain 115 (6):1701–25. doi: https://doi.org/10.1093/brain/115.6.1701.
- Council for International Organizations of Medical Sciences (CIOMS). 2016. International Ethical Guidelines for Health-Related Research Involving Humans.
- DeCuir-Gunby, J. T., P. L. Marshall, and A. W. McCulloch. 2011. Developing and using a codebook for the analysis of interview data: An example from a professional development research project. Field Methods 23 (2):136–55. doi: https://doi.org/10.1177/1525822X10388468.
- Emanuel, E. J., D. Wendler, and C. Grady. 2000. What Makes Clinical Research Ethical?. JAMA 283:2701–2711.
- Falagas, M. E., I. P. Korbila, K. P. Giannopoulou, B. K. Kondilis, and G. Peppas. 2009. Informed consent: How much and what do patients understand? American Journal of Surgery 198 (3):420–35. doi: https://doi.org/10.1016/j.amjsurg.2009.02.010.
- Finder, S. G., M. J. Bliton, C. E. Gill, T. L. Davis, P. E. Konrad, and P. D. Charles. 2012. Potential subjects’ responses to an ethics questionnaire in a phase I Study of deep brain stimulation in early Parkinson’s disease. The Journal of Clinical Ethics 23 (3):207–16.
- Flory, J., and E. Emanuel. 2004. Interventions to improve research participants’ understanding in informed consent for research: A systematic review. JAMA 292 (13):1593. doi: https://doi.org/10.1001/jama.292.13.1593.
- Foo, H., E. Mak, T. T. Yong, M. C. Wen, R. J. Chander, W. L. Au, Y. Y. Sitoh, L. C. S. Tan, and N. Kandiah. 2017. Progression of subcortical atrophy in mild Parkinson’s disease and its impact on cognition. European Journal of Neurology 24 (2):341–8. doi: https://doi.org/10.1111/ene.13205.
- Glaser, J., S. Nouri, A. Fernandez, R. L. Sudore, D. Schillinger, M. Klein-Fedyshin, and Y. Schenker. 2020. Interventions to improve patient comprehension in informed consent for medical and surgical procedures: An updated systematic review. Medical Decision Making : An International Journal of the Society for Medical Decision Making 40 (2):119–43. doi: https://doi.org/10.1177/0272989x19896348.
- Goldman, J. G., and I. Litvan. 2011. Mild cognitive impairment in Parkinson’s disease. Minerva Medica 102 (6):441–59.
- Grady, C., G. Bedarida, N. Sinaii, M. A. Gregorio, and E. J. Emanuel. 2017. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research. Clinical Trials 14 (5):526–36. doi: https://doi.org/10.1177/1740774517722130.
- Henderson, G. E., L. R. Churchill, A. M. Davis, M. M. Easter, C. Grady, S. Joffe, N. Kass, N. M. P. King, C. W. Lidz, F. G. Miller, et al. 2007. Clinical trials and medical care: Defining the therapeutic misconception. PLoS Medicine 4 (11):e324 doi: https://doi.org/10.1371/journal.pmed.0040324.
- Hendriks, S., C. Grady, K. M. Ramos, W. Chiong, J. J. Fins, P. Ford, S. Goering, H. T. Greely, K. Hutchison, M. L. Kelly, et al. 2019. Ethical challenges of risk, informed consent, and posttrial responsibilities in human research with neural devices. JAMA Neurology 76 (12):1506–14. doi: https://doi.org/10.1001/jamaneurol.2019.3523.
- Karlawish, J., M. Cary, S. T. Moelter, A. Siderowf, E. Sullo, S. Xie, and D. Weintraub. 2013. Cognitive impairment and PD patients’ capacity to consent to research. Neurology 81 (9):801–7. doi: https://doi.org/10.1212/wnl.0b013e3182a05ba5.
- Kim, S. Y. H., R. De Vries, S. Parnami, R. Wilson, H. Myra Kim, S. Frank, R. G. Holloway, and K. Kieburtz. 2015. Are therapeutic motivation and having one’s own doctor as researcher sources of therapeutic misconception? Journal of Medical Ethics 41 (5):391–7. doi: https://doi.org/10.1136/medethics-2013-101987.
- Kim, S. Y. H., R. M. Wilson, H. Myra Kim, R. G. Holloway, R. G. De Vries, S. A. Frank, and K. Kieburtz. 2012. Comparison of enrollees and decliners of Parkinson disease sham surgery trials. Movement Disorders 27 (4):506–11. doi: https://doi.org/10.1002/mds.24940.
- Kulisevsky, J., C. García-Sánchez, M. L. Berthier, M. Barbanoj, B. Pascual-Sedano, A. Gironell, and A. Estévez-González. 2000. Chronic effects of dopaminergic replacement on cognitive function in Parkinson’s disease: A two-year follow-up study of previously untreated patients. Movement Disorders 15 (4):613–26. doi: https://doi.org/10.1002/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F.
- Locock, L., and L. Smith. 2011. Personal benefit, or benefiting others? Deciding whether to take part in clinical trials. Clinical Trials 8 (1):85–93. doi: https://doi.org/10.1177/1740774510392257.
- Mamikonyan, E., P. J. Moberg, A. Siderowf, J. E. Duda, T. T. Have, H. I. Hurtig, M. B. Stern, and D. Weintraub. 2009. Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism & Related Disorders 15 (3):226–31. doi: https://doi.org/10.1016/j.parkreldis.2008.05.006.
- Mergenthaler, J. V., W. Chiong, D. Dohan, J. Feler, C. R. Lechner, P. A. Starr, and J. J. Arias. 2021. A qualitative analysis of ethical perspectives on Recruitment and consent for human intracranial electrophysiology studies. AJOB Neuroscience 12 (1):57–67. doi: https://doi.org/10.1080/21507740.2020.1866098.
- Moelter, S. T., D. Weintraub, L. Mace, M. Cary, E. Sullo, S. X. Xie, and J. Karlawish. 2016. Research consent capacity varies with executive function and memory in Parkinson’s disease. Movement Disorders 31 (3):414–7. doi: https://doi.org/10.1002/mds.26469.
- Morain, S. R., S. Joffe, and E. A. Largent. 2019. When is it ethical for physician-investigators to seek consent from their own patients? The American Journal of Bioethics 19 (4):11–8. doi: https://doi.org/10.1080/15265161.2019.1572811.
- Nishimura, A., J. Carey, P. J. Erwin, J. C. Tilburt, M. H. Murad, and J. B. McCormick. 2013. Improving understanding in the research informed consent process: A systematic review of 54 interventions tested in randomized control trials. BMC Medical Ethics 14 (1):28 doi: https://doi.org/10.1186/1472-6939-14-28.
- Ramayya, A. G., I. Pedisich, D. Levy, A. Lyalenko, P. Wanda, D. Rizzuto, G. H. Baltuch, and M. J. Kahana. 2017. Proximity of substantia nigra microstimulation to putative GABAergic neurons predicts modulation of human reinforcement learning. Frontiers in Human Neuroscience 11:200. doi: https://doi.org/10.3389/fnhum.2017.00200.
- Ramayya, A. G., K. A. Zaghloul, C. T. Weidemann, G. H. Baltuch, and M. J. Kahana. 2014. Electrophysiological evidence for functionally distinct neuronal populations in the human substantia nigra. Frontiers in Human Neuroscience 8:655. doi: https://doi.org/10.3389/fnhum.2014.00655.
- Ravina, B., C. Swearingen, J. Elm, C. Kamp, K. Kieburtz, and S. Y. H. Kim. 2010. Long term understanding of study information in research participants with Parkinson’s disease. Parkinsonism & Related Disorders 16 (1):60–3. doi: https://doi.org/10.1016/j.parkreldis.2009.05.007.
- Sachs, G. A., G. W. Hougham, J. Sugarman, P. Agre, M. E. Broome, G. Geller, N. Kass, E. Kodish, J. Mintz, L. W. Roberts, et al. 2003. Conducting empirical research on informed consent: Challenges and questions. IRB: Ethics and Human Research 25 (5):S4. doi: https://doi.org/10.2307/3564116.
- Sankar, P. 2004. Communication and miscommunication in informed consent to research. Medical Anthropology Quarterly 18 (4):429–46. doi: https://doi.org/10.1525/maq.2004.18.4.429.
- Sankar, P., P. Root Wolpe, N. L. Jones, and M. Cho. 2006. How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States. Community Genetics 9 (2):78–86. doi: https://doi.org/10.1159/000091484.
- Stunkel, L., and C. Grady. 2011. More than the money: A review of the literature examining healthy volunteer motivations. Contemporary Clinical Trials 32 (3):342–52. doi: https://doi.org/10.1016/j.cct.2010.12.003.
- Tekriwal, A., N. Moin Afshar, J. Santiago-Moreno, F. M. Kuijper, D. S. Kern, C. H. Halpern, G. Felsen, and J. A. Thompson. 2019. Neural circuit and clinical insights from intraoperative recordings during deep brain stimulation surgery. Brain Sciences 9 (7):173. doi: https://doi.org/10.3390/brainsci9070173.
- Tishler, C. L., and S. Bartholomae. 2002. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. The Journal of Clinical Pharmacology 42 (4):365–75. doi: https://doi.org/10.1177/00912700222011409.
- Tromp, K., C. Michel Zwaan, and S. van de Vathorst. 2016. Motivations of children and their parents to participate in drug research: A systematic review. European Journal of Pediatrics 175 (5):599–612. doi: https://doi.org/10.1007/s00431-016-2715-9.
- Truong, T. H., J. C. Weeks, E. F. Cook, and S. Joffe. 2011. Altruism among participants in cancer clinical trials. Clinical Trials 8 (5):616–23. doi: https://doi.org/10.1177/1740774511414444.
- Vaishnav, N., and W. Chiong. 2018. Informed consent for the human research subject with a neurologic disorder. Seminars in Neurology 38 (5):539–47. doi: https://doi.org/10.1055/s-0038-1668077.
- Valadas, A., M. Coelho, T. Mestre, L. Correia Guedes, M. Finisterra, A. Noronha, M. M. Rosa, C. Sampaio, and J. J. Ferreira. 2011. What motivates Parkinson’s disease patients to enter clinical trials? Parkinsonism & Related Disorders 17 (9):667–71. doi: https://doi.org/10.1016/j.parkreldis.2011.05.023.
- Verheggen, F. W. S. M., and F. C. B. van Wijmen. 1996. Informed consent in clinical trials. Health Policy 36 (2):131–53. doi: https://doi.org/10.1016/0168-8510(95)00805-5.